Mednet Logo

Would you consider SBRT for an inoperable T1-T2 N0 SCLC?

If so, would you recommend adjuvant chemotherapy and PCI after?
Community PollStarted

How do you manage inoperable T1-T2N0 SCLC?

349 physicians have voted

Join Mednetto vote and see how they answered.

7 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Washington University School of Medicine
Answered on

The concept of using SBRT in the setting of inoperable early-stage node negative small cell lung cancer (SCLC) is interesting and replicates the concept of SBRT as a surgical surrogate. In other words, SBRT is used to manage the primary lesion, as with early-stage non-small cell lung cancer (NSCLC)....

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on

The standard is surgical resection. As some are medically impaired, TRT options include SBRT, I know of no data or series. My practice has been 45 Gy/3wks. Also not evidence-based. Some of these nodules may sample just SCLC, but harbor carcinoid or NSCLC.

In resected, 4 Cycles Plat/Etop.

Low inciden...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan Kettering Cancer Center
Answered on

As @Dr. First Last says, the concept of using SBRT as a surgical surrogate for early-stage SCLC is rational. We have not routinely done this at our center and for now, I'd still consider the standard of care (for inoperable patients) to be concurrent chemoradiation to 45Gy BID. Other data is likely ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina
Answered on

I have used both SBRT followed by platinum/etoposide, SBRT alone, and the hyperfractionated 4500 cGy with 150 cGy BID regimen with concurrent platinum/etoposide. This is not common for an SCLC presentation and patient preference and co-morbidities need to be considered in determining the appropriate...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Bismarck Cancer Center
Answered on

For those seeking additional references to support SBRT (SABR) for stage I SCLC, a nice editorial/review by Drs. Verma, @Dr. First Last, and @Dr. First Last can be found at the Oncologist PMID 26764248, ahead of several additional publications by the same authors (PMID 28011047, PMID 28408183, PMID ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on

No N-0 in Intergroup trial. One might pose this to CONVERT and recent Scandinavian trialists. Overview of surgically treated N-0 showed a low incidence of CNS failure.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Jacob E Locke MD PA
Answered on

The EQD and BEDs go up from 45 BID to 60 BID to 70 Gy to 50/5 SBRT. CALGB says 70 is as good as 45 BID at nearly 5 years.

For elderly, comorbid patients, and T1N0 patients, it seems like SBRT + chemo is reasonable. Is EBUS mandatory first or is a reasonable PET result sufficient (groans from the cr...

Join for free or sign in to see the full answer